• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • DACH

Equita purchases Windstar Medical

  • Harriet Bailey
  • Harriet Bailey
  • 10 December 2014
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Equita Management has acquired a majority stake in Windstar Medical, a producer of non-prescription drugs, alongside management.

The deal value is understood to be between €50-100m.

Equita invested via its Equita Holding and Equita CoVest vehicles. Equita CoVest held a final close on €135m and invests exclusively alongside Equita's other funds. Equita Holding is a €315m evergreen fund first set up in 2007.

Windstar Medical

  • DEAL:

    MBO

  • LOCATION:

    Wehrheim

  • SECTOR:

    Pharmaceuticals

  • FOUNDED:

    1993

  • TURNOVER:

    €60m

  • STAFF:

    100

The official transfer of ownership will occur on 15 December. The existing management team and staff will continue to run Windstar Medical, with the company's founders retaining a significant stake.

Equita will support Windstar's continuing international expansion.

Its purchase comes shortly after divesting conveyor belt manufacturer Transnorm to IK Investment Partners in late November.

Company
Windstar can trace its roots back to 1993, when the founders set up Promarcon, a marketing and consulting company. This incorporated the three groups: Claricon, a consumer service and market research company; branding and consulting firm Brand Scout; and PureArt, a packaging design and communication business. Districon and Dr Kleine Pharma, the distribution entities, were set up in 1999. In 2008, the companies merged to form Windstar Medical.

Headquartered in Wehrheim, with additional offices in Bielefeld and Würzburg, its non-prescription health products are sold in non-pharmacy outlets, such as supermarkets. It covers all aspects of healthcare from product development to customer service and sales. As well as creating new drugs, it also redesigns prescription drugs for the mass market.

Windstar's own brands include SOS, Well&Slim and GreenDoc. It has also set up online shop Good Vita. It generates sales of around €60m per year and has 100 employees.

People
Wilfried Eichhorn and Thomas Kleine are co-founders of Windstar. Hansjörg Schnabel is a managing director at Equita and was accompanied by Jan Drewitz and Matthias Tabbert on the deal.

Advisers
Equity – Lukas & Company (Commercial due diligence); Ebner Stolz (Financial due diligence); Watson Farley & Williams (Legal, tax, corporate finance); Forstmann & Büttner (Regulatory due diligence); Mesterheide (Insurance due diligence).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • DACH
  • Buyouts
  • Healthcare
  • Germany
  • EQUITA Management

More on DACH

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Jan Cerny of BHM Group
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • Investments
  • 01 September 2023
Bettina Curtze of Redalpine
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013